IBU-tec advanced materials AG

  • ISIN: DE000A0XYHT5
  • Land: Deutschland

Nachricht vom 29.04.2021 | 14:52

​​​​​​​IBU-tec advanced materials AG: Annual General Meeting approves all agenda items with a clear majority

DGAP-News: IBU-tec advanced materials AG / Key word(s): AGM/EGM
29.04.2021 / 14:52
The issuer is solely responsible for the content of this announcement.

IBU-tec advanced materials AG: Annual General Meeting approves all agenda items with a clear majority

Weimar, 29 April 2021 - The shareholders of IBU-tec advanced materials AG ("IBU-tec", ISIN: DE000A0XYHT5) approved at today's ordinary Annual General Meeting all agenda items with a very large majority. At the Annual Meeting, which was held virtually again this year, altogether 64.03 percent of the share capital were represented.

The General Meeting resolved, among other things, to create a new authorised capital. The shareholders also approved all the other items on the agenda by a large majority.

Ulrich Weitz, CEO of IBU-tec advanced materials AG: "I thank all the shareholders represented for their trust and approval. At this year's Annual Meeting we were pleased to welcome many new investors virtually, after the free float rose to around 51.89 percent following the capital increase successfully completed in March 2021."

The detailed voting results are available on the website of IBU-tec under:

The speech by the Management Board can be viewed as a video stream under the following link:

About IBU-tec

The IBU-tec Group develops and produces innovative materials of the highest quality for the industry. It combines unique, partly patent-protected thermal process engineering, with the process and material know-how of around 250 highly qualified employees. The products include important components of battery materials for electric mobility and stationary energy storage, as well as solutions for air purification, resource conservation or the reduction of plastic packaging. IBU-tec is thus in a long-term position to respond to global mega trends, especially in the fields of climate and environmental protection. It has an international customer base ranging from innovative medium-sized companies to global corporations.
Further information can be found online at www.ibu-tec.de.


edicto GmbH
Axel Mühlhaus
Eschersheimer Landstraße 42-44
60322 Frankfurt
Tel. +49 (0) 69-905505-52
Email: IBU-tec@edicto.de

29.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

FORTEC Elektronik Aktiengesellschaft

Original-Research: FORTEC Elektronik AG (von Montega AG): Kaufen

29. November 2021